Clinical trials
Cost Effectiveness clinical trials
Below are recruiting cost effectiveness clinical trials, each written for real people, not researchers. We’re tracking 68 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06567340Recruiting
AI-guided care for depression in talking therapies
This trial tests whether an AI tool can help therapists choose the best treatment for depression. If you are 18 or older and have significant depression symptoms (PHQ-9 score of 10 or more), you may be able to join if you are already being treated at a participating Talking Therapies service.
Darlington, DurhamAges 18 years+ - NCT04031820Recruiting
Comparing two hip cup types to prevent dislocation
This trial compares a “dual-mobility” hip cup to a “unipolar” hip cup during primary hip replacement, focusing on dislocation (the hip coming out of place) and overall cost-effectiveness. It may help your care team choose the best implant for you and monitor outcomes after surgery.
AmsterdamAges 70 years+ - NCT04234971RecruitingPhase 4
Compare costs of bone grafting for cleft jaw repair
This study looks at whether alveolar bone graft surgery is cost-effective for people with cleft lip and palate. It may help clinics choose the most practical approach for the best outcomes while managing overall costs.
Houston, TexasAges 6–15 - NCT04433052Recruiting
Personalized heart-protection program for people at high risk
This trial tests whether a tailored prevention plan can improve outcomes and help with costs for people at high risk of coronary heart disease. You may join if you’ve had recent heart events or scans show significant blockage, and if you can follow the visit and app requirements.
HelsinkiAges 30–80 - NCT04623593Recruiting
Study of cost and value of neck disc surgery
This study looks at how cost-effective (good value for the money) anterior neck disc surgery is for people with nerve or spinal cord symptoms. If you need this type of operation, it may help doctors better choose treatments and plan healthcare resources.
Maastricht, LimburgAges 18 years+ - NCT05078671RecruitingPhase 4
Testing a drug-boost to improve olaparib levels and side effects
This Phase 4 study tests whether adding a “booster” medicine can raise olaparib levels in the body so it may be better tolerated and more cost-effective. You may be eligible if you are already taking olaparib and meet health and medication safety requirements.
's-HertogenboschAges 18 years+ - NCT05168462RecruitingPhase 4
Lower blood pressure goal in heart-attack shock patients
This study compares two blood pressure targets in people with cardiogenic shock after a heart attack. It looks at whether the lower target can improve outcomes and help evaluate treatment costs.
AmsterdamAges 18 years+ - NCT05588115Recruiting
Test blood biomarkers to help diagnose concussion
This study checks whether a blood test can accurately and quickly identify an uncomplicated concussion. It may help doctors confirm concussion sooner and more reliably, and potentially reduce time and cost of diagnosis.
Calgary, AlbertaAges 18–65 - NCT05677269Recruiting
Compare surgery for bowel endometriosis versus IVF pathway
This trial studies whether surgically removing colorectal (bowel) endometriosis works better and is more cost-effective than choosing an IVF/ICSI treatment plan. It’s for people who want to get pregnant and are deciding between surgery and fertility treatments.
EindhovenAges 21–40 - NCT05748093RecruitingPhase 4
Boost osimertinib levels using cobicistat to improve value
This study tests whether adding cobicistat can increase and stabilize the effect level of osimertinib while keeping treatment cost-effective. You would take osimertinib 80 mg daily, with blood tests to see how your body processes the drug.
Maastricht, LimburgAges 18 years+ - NCT05774548Recruiting
Study of PrEP use and its cost in HIV prevention
This study looks at how taking PrEP (medicine to prevent HIV) affects HIV prevention and how much it costs in real life. You may be able to join if you are HIV-negative and are interested in starting, currently using, or have used PrEP before.
Bangkok, BangkapiAges 18 years+ - NCT05812950Recruiting
Group therapy for complex eating disorders with cost review
This study tests whether group schema therapy helps people with complex eating disorders and also looks at whether it is cost-effective. It may help if you have anorexia nervosa, bulimia nervosa, or a related diagnosis and can take part in Dutch-language group sessions.
BredaAges 16 years+ - NCT06140589Recruiting
Cadonilimab for advanced cervical cancer
This trial tests a new immunotherapy drug called cadonilimab for women with cervical cancer that has returned, spread, or is advanced. The goal is to see if it works well, how safe it is, and if it costs less than standard treatments.
Fuzhou, FujianAges 18–80 - NCT06278974Recruiting
Comparing myopia treatments for kids: glasses vs ortho-k
This study compares three ways to slow down nearsightedness in children: special glasses (defocus lenses), regular glasses, and orthokeratology contact lenses (worn overnight). It aims to find which works best for kids who have never worn glasses before.
Shenyang, LiaoningAges 7–17 - NCT06416345Recruiting
Cue2Walk: Freezing detection and cues for Parkinson's walking
This study tests whether a new device called Cue2Walk can help people with Parkinson's disease who have freezing of gait. The device detects when you freeze and sends a signal (like a beep) to help you start walking again. Researchers want to see if it is worth the cost compared to your usual care.
Nijmegen, GelderlandAges Any age - NCT06491667Recruiting
Simple blood tests to predict heart attack recovery
This study is checking if two simple, inexpensive blood tests (NLR and CRP) can help predict how well someone with a certain type of heart attack (STEMI) will do. It aims to find a cheaper way to guide treatment and monitor recovery.
SohagAges 18 years+ - NCT06493370RecruitingPhase 2
IV vitamin C plus chemo for bladder cancer
This trial tests adding high-dose vitamin C (ascorbate) to a standard chemotherapy combination for people with muscle-invasive bladder cancer who cannot take or choose not to take cisplatin. The goal is to find a more affordable and effective treatment option.
Iowa City, IowaAges 18 years+ - NCT06598397RecruitingPhase 4
Quit smoking help for people with HIV in NYC
This study is testing different ways to help people with HIV quit smoking. It combines medication, coaching, and text messages to find the most affordable and effective support.
New York, New YorkAges 18 years+ - NCT06603831Recruiting
3D digital surgery study for bone and joint procedures
This study tests whether 3D digital planning tools make surgeries for certain bone and joint problems more effective and cost-efficient. If you need a specific type of surgery on your forearm, pelvis, or spine, this trial could help determine if digital surgery improves your recovery.
Sabadell, BarcelonaAges 18–80 - NCT06685367Recruiting
AI software for predicting acute kidney injury in ICU
This trial tests software that uses artificial intelligence to predict if a patient in the ICU might develop acute kidney injury (sudden kidney damage). It aims to see if the software is cost-effective and could help doctors catch problems earlier.
TaichungAges 20 years+ - NCT06727409RecruitingPhase 4
Triple therapy for type 2 diabetes and kidney disease
This study tests whether adding a non-steroidal mineralocorticoid antagonist to your current type 2 diabetes and kidney disease medications (SGLT2i and ACEi/ARB) is cost-effective. It may help preserve kidney function and reduce heart risks.
Hong KongAges 18 years+ - NCT06789380Recruiting
Generalist vs specialist care for severe personality disorders
This trial compares two types of treatment—generalist care by a therapist or specialist care—for people with severe personality disorders. It aims to find which approach works better and is more cost-effective.
Halsteren, North BrabantAges 18 years+ - NCT06832852Recruiting
Comparing cost-effective care for muscle and joint pain
This study compares different models of care to find the most cost-effective way to treat common muscle and joint problems (like back, neck, knee, or shoulder pain). It looks at which approach works best for patients with persistent pain to guide future treatment decisions.
Québec, QuebecAges 18–65 - NCT06856902Recruiting
A study on a behavioral program to improve healthcare
This study tests a behavioral program to help people stick with their healthcare plan. It aims to improve health and lower costs.
DüsseldorfAges Any age
Hear when a new Cost Effectiveness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cost effectiveness?
- Yes. Clin2 currently lists 68 recruiting cost effectiveness studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cost effectiveness trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cost effectiveness trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.